The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
暂无分享,去创建一个
[1] San-Gang Wu,et al. The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status , 2016, Cancer medicine.
[2] N. Park,et al. Prognostic factors in neuroendocrine cervical carcinoma , 2016, Obstetrics & gynecology science.
[3] M. Zheng,et al. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients , 2014, BMC Cancer.
[4] J. Chan,et al. The management of small-cell carcinomas of the gynecologic tract , 2012, Current opinion in oncology.
[5] P. Gehrig,et al. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. , 2011, Gynecologic oncology.
[6] J. Chan,et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. , 2010, American journal of obstetrics and gynecology.
[7] Y. Seto,et al. Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. , 2008, Japanese journal of clinical oncology.
[8] J. Nam,et al. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] L. Clegg,et al. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. , 2003, Gynecologic oncology.
[10] R. Burger,et al. Prognostic factors in neuroendocrine small cell cervical carcinoma , 2003, Cancer.
[11] K. Mori,et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. , 2002, The New England journal of medicine.
[12] F. Landoni,et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer , 1997, The Lancet.